Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 January 2024 | Story Anthony Mthembu | Photo Supplied
Michelle de Lange
Michelle De Lange: The winner of the ‘Elite University Educator’ award announced at the first AICPA & CIMA CGMA Professional Awards Africa ceremony.

The University of the Free State (UFS) has proudly clinched two prestigious awards at the inaugural Chartered Global Management Accountant (CGMA) Leadership Award ceremony. Organised by the Association of International Certified Professional Accountants, comprising AICPA and CIMA, this event recognises the outstanding contributions to the finance and accounting industry on the continent.

Top university accolade

UFS secured the coveted CGMA Leadership Award for ‘Excellent University Partner (Top 10 in Africa).’ This accolade underscores the institution's commitment to advancing the finance and accounting sector. The presentation took place at the awards ceremony held in Johannesburg on 24 November 2023, marking a significant achievement for the UFS.

Prof Frans Prinsloo, Vice-Dean of Learning, Teaching, Innovation, and Digitalisation in the Economic and Management Sciences (EMS) Faculty at the UFS, views the award as a testament to the alignment of the academic programmes with the standards of leading professional accountancy bodies in South Africa, including the Chartered Institute of Management Accountants (CIMA).

Prinsloo stated, “We have worked diligently to align our academic programmes with the requirements of key potential professional bodies, positioning ourselves as an educator of choice. This recognition, alongside our other accreditations, confirms our success in achieving this goal.”

A global educator recognised

Further enhancing the UFS’s recognition, Michelle de Lange, Lecturer in the School of Accountancy and Programme Coordinator of the B.Com Honours in Management Accounting, received the ‘Elite University Educator of the Year Award’ in the CGMA Leadership Award category. Nominated by her students and colleagues, De Lange expressed her honour and surprise at winning, highlighting her commitment to delivering valuable content to her students.

De Lange shared her perspective, stating, “To compete against phenomenal educators was a privilege, and winning signifies that my efforts are making a positive impact on students and colleagues alike.”

According to Prinsloo and De Lange, these accolades affirm the institution’s dedication to producing top-class accountancy and finance graduates.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept